Therapeutical strategies for anxiety and anxiety-like disorders using plant-derived natural compounds and plant extracts
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16370%2F17%3A43875998" target="_blank" >RIV/62157124:16370/17:43875998 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1016/j.biopha.2017.08.107" target="_blank" >http://dx.doi.org/10.1016/j.biopha.2017.08.107</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.biopha.2017.08.107" target="_blank" >10.1016/j.biopha.2017.08.107</a>
Alternative languages
Result language
angličtina
Original language name
Therapeutical strategies for anxiety and anxiety-like disorders using plant-derived natural compounds and plant extracts
Original language description
Anxiety and anxiety-like disorders describe many mental disorders, yet fear is a common overwhelming symptom often leading to depression. Currently two basic strategies are discussed to treat anxiety: pharmacotherapy or psychotherapy. In the pharmacotherapeutical clinical approach, several conventional synthetic anxiolytic drugs are being used with several adverse effects. Therefore, studies to find suitable safe medicines from natural sources are being sought by researchers. The results of a plethora experimental studies demonstrated that dietary phytochemicals like alkaloids, terpenes, flavonoids, phenolic acids, lignans, cinnamates, and saponins or various plant extracts with the mixture of different phytochemicals possess anxiolytic effects in a wide range of animal models of anxiety. The involved mechanisms of anxiolytics action include interaction with gamma-aminobutyric acid A receptors at benzodiazepine (BZD) and non-BZD sites with various affinity to different subunits, serotonergic 5-hydrodytryptamine receptors, noradrenergic and dopaminergic systems, glutamate receptors, and cannabinoid receptors. This review focuses on the use of both plant-derived natural compounds and plant extracts with anxiolytic effects, describing their biological effects and clinical application.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Biomedicine & pharmacotherapy
ISSN
0753-3322
e-ISSN
—
Volume of the periodical
95
Issue of the periodical within the volume
NOV 2017
Country of publishing house
FR - FRANCE
Number of pages
10
Pages from-to
437-446
UT code for WoS article
000417744400052
EID of the result in the Scopus database
—